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This paper presents the results of the study of associations of polymorphic loci of chemokines 
(+1931А/Т ССL4 (rs1719153), A/G CXCL11 (rs4512021), -403A/G CCL5 (rs2107538), C/G CCL2 (rs2857657), -
801G/A CXCL12 (rs1801157)) with renal survival in patients with chronic glomerulonephritis. It was established 
that AA and CXCL11 AG genotypes (rs4512021) (p=0.05) are the marker of high creatinine level in patients with 
chronic glomerulonephritis.  
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INTRODUCTION 
 
Chronic kidney disease (CKD) occupies a special place among chronic non-infectious diseases, as it is 
widespread, associated with a sharp deterioration in the quality of life, high mortality, and leads in the 
terminal stage to the need for expensive replacement therapy – dialysis and kidney transplantation (Sigdel et 
al., 2012; Lebherz-Eichinger et al., 2014). It should be noted that a significant proportion of patients with CKD 
are patients with chronic glomerulonephritis (CGN). Chronic glomerulonephritis is characterized by a wide 
variety of clinical manifestations, but in all cases there is a steady and rapid progression of the disease 
(Sorokina et al., 2016). Chronic glomerulonephritis is of undulating nature, when the period of remission 
alternates with exacerbation, when the clinical findings resemble or become similar to acute 
glomerulonephritis. 
 
At present, the involvement of the genetic component in the development and progression of chronic 
kidney disease, including CGN, is actively studied [Piotrowski et al., 2010; Litovkina et al., 2014a; Bagci et al., 
2015]. According to modern literature, chemokines play an important role in the development of renal 
pathologies [Anders et al., 2010], which are able to control the migration of various types of leukocytes with 
the relative receptors from the bloodstream to the tissues, inflammation foci, autoimmune process, 
participate in activation and differentiation of leukocytes, angiogenesis, fibrogenesis (Lo et al., 2011). 
However, it is worth noting that the importance of the genetic factors of chemokines in the development of 
chronic kidney disease has not been sufficiently studied; the available research results are presented mainly in 
foreign sources [Piotrowski et al., 2010; Litovkina et al., 2014b; Bagci et al., 2015], while in the Russian 
Federation such works are rare. 
 
Objective of this study was to evaluate the polymorphic loci of chemokines (rs1719153, rs4512021, 
rs2107538, rs2857657 CCL2, rs1801157 CXCL12) as possible markers of accelerated impairment of the renal 
function in patients with chronic kidney disease. 
 
MATERIALS AND METHODS 
 
The analysis of polymorphic loci of chemokines was conducted in 700 people: 238 patients with 
chronic glomerulonephritis (mean age 39.58±14.58 years) and 462 controls (42.12±5.19 years, p>0.05). 
Formation of samples of patients and the control was carried out by a continuous method in the period from 
2009 to 2011. The samples included Russian natives of the Central Black Earth region of Russia having no 
family ties with each other. The patients were included in the study group only after the diagnosis of the 
disease, confirmed with the help of clinical and laboratory-instrumental methods of examination, by the staff 
of the Nephrology Unit of St. Joasaph Belgorod Regional Clinical Hospital. The investigated groups of patients 
with CGN and control are comparable by gender, age characteristics, place of birth and nationality.  
 
As the material for the study we used 8-9 ml of venous blood taken from the cubital vein of a 
proband. A genomic DNA was isolated from peripheral blood by standard methods (Miller et al., 1988). 
 
Analysis of all loci was carried out by the method of polymerase chain reaction of DNA synthesis with 
the use of standard primers and probes. Genotyping of DNA markers was performed by the method of analysis 
of allelic discrimination by the Taq-Man probe method with real-time PCR. 
 
To assess the compliance of the observed distribution of genotypes with the expected one, based on 
Hardy-Weinberg equilibrium, we used 2 test, the observed heterozygosity, the expected heterozygosity, and 
the Wright fixation index. A comparison of the study groups of patients by the level of creatinine was carried 
out using the Mann-Whitney test; median (Me) and interquartile range (Q25-Q75) were used for the 
description. During the study, the heterozygote group was combined with that group of homozygotes that had 
no differences in median and interquartile interval values from heterozygous carriers or were the least. 
 
Analysis of associations of renal survival with polymorphic genetic markers was carried out using the 
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RESULTS AND DISCUSSION 
 
All patients with CGN and individuals in the control group underwent typing of five molecular-genetic 
markers of chemokines: regulator of normal T-cell expression activity (rs2107538), β-cell precursor growth 
factor (rs1801157), monocyte chemoattractant protein 1 (rs2857657), interferon-inducible α T-cell 
chemoattractant (rs4512021), and macrophage inflammatory protein 1β (rs1719153). 
 
The study of the distribution of the genotypes of the studied polymorphic loci of chemokines showed 
that for all the genetic polymorphisms examined in the control sample and in the group of CGN patients, the 
empirical distribution of the genotypes corresponds to the theoretically expected at Hardy-Weinberg 
equilibrium (p>0.05). Comparative analysis of the frequencies of alleles and genotypes of the investigated loci 
among patients with CGN and control group revealed no statistically significant differences (p>0.05). 
 
Next, the following quantitative pathogenetically significant indices in CGN patients were examined: 
the age of the manifestation of the disease, the level of creatinine, hematuria, and proteinuria. Since the 
distribution of the analyzed indicators, estimated using the Shapiro-Wilk test, does not correspond to the law 
of normal distribution (p<0.05) (Table 1), the median (Me) and interquartile range (Q25-Q75) were used to 
describe the quantitative indices in question, and for comparison of individuals with different genotypes by 
these parameters a nonparametric method - the Mann-Whitney test - was used. 
 
Table 1:The distribution of quantitative indicators in patients with chronic glomerulonephritis 
 




 238 27.50 17.00 41.00 0.97 <0.01 
Creatinine 
level, μmol/L 
 238 112.50 93.90 456.00 0.72 <0.01 
Hematuria 
level,  units 
 238 6.00 2.00 12.00 0.39 <0.01 
Proteinuria 
level, g/day 
 232 0.50 0.20 1.53 0.50 <0.01 
Notes: N, sample size; Me, median; Q25 - Q75, interquartile range - the 25th and 75th percentiles; W, Shapiro-
Wilk test. P values were calculated using the Shapiro-Wilk test. 
 
The study of the links of the chemokine loci in question with these pathogenetically significant 
quantitative indicators revealed significant associations only for CXCL11 A/G genetic polymorphism (rs 
4512021) with the creatinine level in CGN patients (Table 2). CGN patients with CXCL11 AA and AG genotypes 
have significantly higher creatinine levels (median 119.0 μmol/l lower quartile 94.4 μmol/l, upper quartile 
541.0 μmol/l compared to individuals with the GG genotype (median 101.0 μmol/l, interquartile interval - 
87.0-181.0 μmol/l, p=0.05, respectively.) Thus, the data obtained may indicate that the CXCL11 A/G locus 
(rs4512021) is associated with a renal function. 
 
The evaluation of renal survival in patients with CGN, depending on the genetic polymorphisms of 
chemokines, conducted using the Kaplan-Meyer multiplier method, which allows determining the influence of 
any factors, including genetic ones, on a time before the onset of the studied outcome (renal function 
impairment) presented the following results: rs1719153, p=0.58; rs4512021, p=0.78; rs2107538, p=0.46; 
rs2857657; rs1801157, p=0.32. We should note the absence of statistically significant associations of 
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Table 2: The level of creatinine in patients with chronic glomerulonephritis, depending on the genetic 
polymorphisms of chemokines 
 
SNP Genotype 
Level of creatinine, μmol/L 
N Ме Q25-Q75 
rs1719153 
+1931АА 114 110.5 92.5-313.0 
+1931АТ, +1931ТТ 111 119.0 93.2-685.0 
р >0.05 
rs2107538 
-403AA 4 180.0 135.5-416.5 
-403GG, -403GA 180 110.0 91.65-528.5 
р >0.05 
rs 2857657 
GG 10 95.0 71.00-54.0 
CC, CG 218 112.5 94.0-401.0 
р >0.05 
rs1801157 
-801AA 8 102.0 98.0-329.0 
-801GG, -801GA 218 112.0 92.5-401.0 
р >0.05 
rs4512021 
АА, АG 218 119.0 94.4-541.0 
GG 8 101.0 87.0-181.0 
р 0.05 
Notes: N, sample size; Me, median; Q25 - Q75, interquartile range - the 25th and 75th percentiles. P values 
were calculated using the  Mann-Whitney U-test. 
 
According to current literature, a β-cell precursor growth stimulating factor (stromal cell factor - 
CXCL12) and interferon-inducible T-cell alpha chemoattractant (CXCL11) play a key role in providing an 
immune response in the chemokine family belonging to the α-chemokine family (Lo et al., 2011). CXCL11 is an 
important chemotactic factor for T-lymphocytes; it activates Th1CD4 T-cells, NK cells, monocytes in the 
inflammatory focus, which ultimately can play an important role in maintaining inflammatory processes in the 
kidney, leading to a decrease in its function. Interferons regulate the production of CXCL11 (Lazzeri et.al., 
2002). Interferon γ in combination with tumor necrosis factors and bacterial liposaccharides stimulates the 
production of interferon-inducible α T-cell chemoattractant by neutrophils. Increased production of CXCL11 




Thus, the study of the links of polymorphic loci of chemokines (rs1719153, rs4512021, rs2107538, 
rs2857657, rs1801157) with renal function in patients with chronic glomerulonephritis revealed that the 
CXCL11 AA and AG genotypes (rs4512021) (p=0.05) are the marker of high creatinine level. No statistically 
significant associations of investigated genetic polymorphisms were detected with the rate of progression of 
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